Skip to main content

Table 2 Clinical features of Mullerian adenosarcoma

From: Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases

Case Age (years) Menopause Macroscopic findings Surgery Adjuvant therapy PFS (month) Site of recurrence OS (month) Status at last follow
Recurrent case
1 50 Menopause polypoid mRH + BSO IEP 6 Retroperitoneal tissue 7 DOD
2 57 Menopause polypoid mRH + BSO + PLA + PALA 71 Lung, Bone 73 DOD
3 66 Menopause polypoid TAH + BSO + PLA + PALA 12 Lung 31 Death of other disease (SAH)
4 65 Menopause polypoid TAH + BSO 10 Unknown site 10 AWD
Non-recurrent case
5 75 Menopause polypoid TAH + BSO 5FU 2   2 NED
6 58 Menopause polypoid mRH + BSO + PLA + PALA 5FU 110   110 NED
7 43 polypoid TAH + BSO + PLA IAP 114   114 NED
  1. BSO bilateral salpingo-oophrectomy, DOD death of disease, IAP: Ifosfamide and doxorubicin and cisplatin, IEP ifosfamide and epirubicin and cisplatin,
  2. 5-FU 5-furuolouracil, mRH modified radical hysterectomy, NED no evidence of disease, PALA paraaortic lymphadnectomy, PLA pelvic lymphadnectomy,
  3. SAH subarachnoid hemorrhage